Necrolytic acral erythema: Response to combination therapy with interferon and ribavirin

Journal of the American Academy of Dermatology

Volumn 50, Issue 5 SUPPL., 2004, Pages 121-124

  Hivnor, Chad M ^a,b   Yan, Albert C ^a,c   Junkins Hopkins, Jacqueline M ^a,b   Honig, Paul J ^a,c  

^a Univ of Pennsylvania Sch of Med ^*

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; INTERFERON; RIBAVIRIN;

ARTICLE; CASE REPORT; DISEASE ASSOCIATION; ERYTHEMA; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; NECROLYTIC ACRAL ERYTHEMA; PRIORITY JOURNAL; SCHOOL CHILD; SKIN DISEASE; TREATMENT OUTCOME; VIRUS HEPATITIS; VIRUS LOAD;

EID: 2342568463     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2003.09.017     Document Type: Article

References (6)

1. El Darouti M, Abu el Ela M. Necrolytic acral erythema: a cutaneous marker of viral hepatitis C. Int J Dermatol 1996;35:252-6.
2. Khanna VJ, Shieh S, Benjamin J, Somach S, Zaim MT, Dorner W, et al. Necrolytic acral erythema associated with hepatitis C: effective treatment with interferon alpha and zinc. Arch Dermatol 2000;136:755-7.
3. Chastain MA. The glucagonoma syndrome: a review of its features and discussion of new perspectives. Am J Med Sci 2001;321:306-20.
4. Swartz RA. Glucagonoma and pseudoglucagonoma syndromes. Int J Dermatol 1997;36:81-9.
5. Sinclair SA, Reynolds NJ. Necrolytic migratory erythema and zinc deficiency. Br J Dermatol 1997;136:783-5.
6. Sintchak MD, Nimmesgern E. The structure of inosine 5′ -monophosphate dehydrogenase and the design of novel inhibitors. Immunopharmacology 2000;47:163-84.